Cecilia Marie Edström
Director/Board Member at NEONODE INC.
Net worth: 5 600 $ as of 2024-03-30
Profile
Cecilia Marie Edström is currently an Independent Director at Neonode, Inc., BioArctic AB, and A3P Biomedical AB.
She previously served as the Chief Executive Officer of Bactiguard AB and Bactiguard Holding AB.
She also held positions as a Non-Executive Director at MegaFon PJSC, an Independent Director at BE Group AB, and a Director at Nordic Public Affairs AB.
Additionally, she worked as the Senior Vice President & Head-Corporate Relations at Scania AB and as the Senior Vice President & Head-Group Communications at Telia Co. AB.
She is a Member of the Governing Council at Stockholm Chamber of Commerce.
Ms. Edström obtained her undergraduate degree from Stockholm School of Economics in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEONODE INC.
0.03% | 2023-04-17 | 4,000 ( 0.03% ) | 5 600 $ | 2024-03-30 |
Cecilia Marie Edström active positions
| Companies | Position | Start |
|---|---|---|
| NEONODE INC. | Director/Board Member | 2022-05-15 |
| BIOARCTIC AB | Director/Board Member | 2023-05-31 |
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Director/Board Member | - |
Former positions of Cecilia Marie Edström
| Companies | Position | End |
|---|---|---|
| BACTIGUARD HOLDING AB | Chief Executive Officer | 2021-09-30 |
Nordic Public Affairs AB
 Nordic Public Affairs AB Miscellaneous Commercial ServicesCommercial Services Nordic Public Affairs AB provides designs and implements public relations campaigns. The company was founded by Martina Lind and Johan Jakobsson and is headquartered in Stockholm, Sweden. | Director/Board Member | 2020-04-30 |
| MEGAFON | Director/Board Member | 2013-08-31 |
| TELIA COMPANY AB | Public Communications Contact | 2013-07-31 |
| BE GROUP AB | Director/Board Member | 2013-04-25 |
Training of Cecilia Marie Edström
| Stockholm School of Economics | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| TELIA COMPANY AB | Communications |
| BE GROUP AB | Distribution Services |
| NEONODE INC. | Electronic Technology |
| BIOARCTIC AB | Health Technology |
| BACTIGUARD HOLDING AB | Health Technology |
| Private companies | 6 |
|---|---|
Scania AB
 Scania AB Motor VehiclesConsumer Durables SCANIA AB engages in the manufacture of commercial vehicles, which include heavy trucks and buses, as well as diesel engines and general industrial appliances. It operates through the Vehicles and Services and Financial Services segments. The Vehicles and Services segment encompasses trucks, buses and engines, including the services associated with these products. The Financial Services segment offers financial solutions such as loan financing, lease contracts, and insurance solutions. The company was founded in 1891 and is headquartered in Sodertalje, Sweden. | Consumer Durables |
MegaFon PJSC
 MegaFon PJSC Wireless TelecommunicationsCommunications MegaFon PJSC engages in the provision of telecommunications services. It offers voice, mobile and fixed-line data transfer, wireless data and wireless broadband services, roaming, short message service, and value-added service, developing business solutions, and sales of mobile phones and other electronics. The company was founded on June 17, 1993 and is headquartered in Moscow, Russia. | Communications |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Distribution Services |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Commercial Services |
Nordic Public Affairs AB
Nordic Public Affairs AB Miscellaneous Commercial ServicesCommercial Services Nordic Public Affairs AB provides designs and implements public relations campaigns. The company was founded by Martina Lind and Johan Jakobsson and is headquartered in Stockholm, Sweden. | Commercial Services |
A3P Biomedical AB
A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Health Services |
- Stock Market
- Insiders
- Cecilia Marie Edström